Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

FDA approves Supernus Pharmaceuticals’ Onapgo to treat advanced Parkinson’s disease

The neurodegenerative disorder affects almost one million people in the US

- PMLiVE

Merck’s adult-specific pneumococcal vaccine Capvaxive recommended by CHMP

Diseases caused by Streptococcus pneumoniae bacteria are considered a “major public health problem” by WHO

- PMLiVE

GenAI and healthcare – potential that goes beyond established technologies

With intuitive interfaces, the ability to handle vast and complex unstructured data and impressive versatility, GenAI is gaining traction

- PMLiVE

Uniphar Expands Global Footprint with Three New Facilities in the USA, Netherlands and Ireland

[Dublin, 05 February 2025] Global partner to pharmaceutical and medtech manufacturers, Uniphar, is expanding its international presence with the launch of three new, state-of-the-art facilities, strategically positioned across key global...

Uniphar

Accession Logo

Accession announces major UK market access consulting milestone

February 5th 2025: Today Accession Healthcare Consulting Ltd (Accession) has announced the achievement of a major consulting milestone as it enters its 15th year as a specialist provider of UK...

Accession

- PMLiVE

UK government launches ‘landmark’ AI breast cancer screening trial

Approximately 55,000 cases of the disease are diagnosed every year in the UK

- PMLiVE

World Cancer Day – CoppaFeel! and NHS NELCA urge young people to ‘Check In’

The co-designed campaign aims to challenge misconceptions surrounding breast cancer

- PMLiVE

Pfizer announces positive phase 3 results for Braftovi regimen in colorectal cancer

An estimated 154,270 people will be diagnosed with cancer of the colon or rectum in the US this year

- PMLiVE

BMS receives CHMP recommendation for Opdivo/Yervoy combination in liver cancer

Hepatocellular carcinoma accounts for approximately 90% of all liver cancer cases globally

- PMLiVE

Celebrating collective achievement – the power of collaboration

How partnerships in the pharma industry have become a cornerstone of progress

- PMLiVE

FlyPharma 2025 Amsterdam officially announced as contracts are signed with host sponsors

The conference will take place in Amsterdam from 8-9 October 2025

- PMLiVE

AstraZeneca’s Imfinzi recommended by CHMP to treat small cell lung cancer

Approximately 30% of small cell lung cancer patients have limited-stage disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links